ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Microbial Therapeutic Product Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-7J14516
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Microbial Therapeutic Product Market Research Report 2023
BUY CHAPTERS

Global Microbial Therapeutic Product Market Research Report 2025

Code: QYRE-Auto-7J14516
Report
July 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roche
Novartis
Amgen Inc
Merck& Co. Inc
Biocon Ltd.
Pfizer Inc
Dr. Reddy’s Laboratories Ltd.
Intas Pharmaceuticals Ltd
Novo Nordisk A S
Eli Lilly and Company
Sanofi
Boehringer Ingelheim
Bristol Myers Squibb Company
Abbot Laboratories
Viatris

Microbial Therapeutic Product Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Microbial Therapeutic Product Market

Microbial Therapeutic Product Market

The global market for Microbial Therapeutic Product was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
As focus on developing therapeutic products that treat and effectively mitigate development of such diseases has gained traction, the commercial prospects have also increased.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Microbial Therapeutic Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microbial Therapeutic Product.
The Microbial Therapeutic Product market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Microbial Therapeutic Product market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Microbial Therapeutic Product companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Microbial Therapeutic Product Market Report

Report Metric Details
Report Name Microbial Therapeutic Product Market
CAGR 5%
Segment by Type
  • Single Use Pre-Filled Injection/Injector Pen
  • Multi-use Injectors
  • Others
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Viatris, Roche, Novartis, Amgen Inc., Merck & Co. Inc., Biocon, Pfizer, Dr. Reddy’s Laboratories Ltd., Intas Pharmaceuticals Ltd., Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Boehringer Ingelheim, Bristol-Myers Squibb Company, Abbot Laboratories
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Microbial Therapeutic Product company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Microbial Therapeutic Product Market report?

Ans: The main players in the Microbial Therapeutic Product Market are Viatris, Roche, Novartis, Amgen Inc., Merck & Co. Inc., Biocon, Pfizer, Dr. Reddy’s Laboratories Ltd., Intas Pharmaceuticals Ltd., Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Boehringer Ingelheim, Bristol-Myers Squibb Company, Abbot Laboratories

What are the Application segmentation covered in the Microbial Therapeutic Product Market report?

Ans: The Applications covered in the Microbial Therapeutic Product Market report are Metabolic Disorders, Haematological Disorders, Oncology, Immunological Disorders, Infectious Diseases, Allergic Diseases, Others

What are the Type segmentation covered in the Microbial Therapeutic Product Market report?

Ans: The Types covered in the Microbial Therapeutic Product Market report are Single Use Pre-Filled Injection/Injector Pen, Multi-use Injectors, Others

Recommended Reports

Infectious Disease Markets

Therapeutic Products

Microbial & Biologicals

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Microbial Therapeutic Product Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Single Use Pre-Filled Injection/Injector Pen
1.2.3 Multi-use Injectors
1.2.4 Others
1.3 Market by Application
1.3.1 Global Microbial Therapeutic Product Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Metabolic Disorders
1.3.3 Haematological Disorders
1.3.4 Oncology
1.3.5 Immunological Disorders
1.3.6 Infectious Diseases
1.3.7 Allergic Diseases
1.3.8 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Microbial Therapeutic Product Market Perspective (2020-2031)
2.2 Global Microbial Therapeutic Product Growth Trends by Region
2.2.1 Global Microbial Therapeutic Product Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Microbial Therapeutic Product Historic Market Size by Region (2020-2025)
2.2.3 Microbial Therapeutic Product Forecasted Market Size by Region (2026-2031)
2.3 Microbial Therapeutic Product Market Dynamics
2.3.1 Microbial Therapeutic Product Industry Trends
2.3.2 Microbial Therapeutic Product Market Drivers
2.3.3 Microbial Therapeutic Product Market Challenges
2.3.4 Microbial Therapeutic Product Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Microbial Therapeutic Product Players by Revenue
3.1.1 Global Top Microbial Therapeutic Product Players by Revenue (2020-2025)
3.1.2 Global Microbial Therapeutic Product Revenue Market Share by Players (2020-2025)
3.2 Global Microbial Therapeutic Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Microbial Therapeutic Product Revenue
3.4 Global Microbial Therapeutic Product Market Concentration Ratio
3.4.1 Global Microbial Therapeutic Product Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Microbial Therapeutic Product Revenue in 2024
3.5 Global Key Players of Microbial Therapeutic Product Head office and Area Served
3.6 Global Key Players of Microbial Therapeutic Product, Product and Application
3.7 Global Key Players of Microbial Therapeutic Product, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Microbial Therapeutic Product Breakdown Data by Type
4.1 Global Microbial Therapeutic Product Historic Market Size by Type (2020-2025)
4.2 Global Microbial Therapeutic Product Forecasted Market Size by Type (2026-2031)
5 Microbial Therapeutic Product Breakdown Data by Application
5.1 Global Microbial Therapeutic Product Historic Market Size by Application (2020-2025)
5.2 Global Microbial Therapeutic Product Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Microbial Therapeutic Product Market Size (2020-2031)
6.2 North America Microbial Therapeutic Product Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Microbial Therapeutic Product Market Size by Country (2020-2025)
6.4 North America Microbial Therapeutic Product Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Microbial Therapeutic Product Market Size (2020-2031)
7.2 Europe Microbial Therapeutic Product Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Microbial Therapeutic Product Market Size by Country (2020-2025)
7.4 Europe Microbial Therapeutic Product Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Microbial Therapeutic Product Market Size (2020-2031)
8.2 Asia-Pacific Microbial Therapeutic Product Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Microbial Therapeutic Product Market Size by Region (2020-2025)
8.4 Asia-Pacific Microbial Therapeutic Product Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Microbial Therapeutic Product Market Size (2020-2031)
9.2 Latin America Microbial Therapeutic Product Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Microbial Therapeutic Product Market Size by Country (2020-2025)
9.4 Latin America Microbial Therapeutic Product Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Microbial Therapeutic Product Market Size (2020-2031)
10.2 Middle East & Africa Microbial Therapeutic Product Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Microbial Therapeutic Product Market Size by Country (2020-2025)
10.4 Middle East & Africa Microbial Therapeutic Product Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Viatris
11.1.1 Viatris Company Details
11.1.2 Viatris Business Overview
11.1.3 Viatris Microbial Therapeutic Product Introduction
11.1.4 Viatris Revenue in Microbial Therapeutic Product Business (2020-2025)
11.1.5 Viatris Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Microbial Therapeutic Product Introduction
11.2.4 Roche Revenue in Microbial Therapeutic Product Business (2020-2025)
11.2.5 Roche Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Microbial Therapeutic Product Introduction
11.3.4 Novartis Revenue in Microbial Therapeutic Product Business (2020-2025)
11.3.5 Novartis Recent Development
11.4 Amgen Inc.
11.4.1 Amgen Inc. Company Details
11.4.2 Amgen Inc. Business Overview
11.4.3 Amgen Inc. Microbial Therapeutic Product Introduction
11.4.4 Amgen Inc. Revenue in Microbial Therapeutic Product Business (2020-2025)
11.4.5 Amgen Inc. Recent Development
11.5 Merck & Co. Inc.
11.5.1 Merck & Co. Inc. Company Details
11.5.2 Merck & Co. Inc. Business Overview
11.5.3 Merck & Co. Inc. Microbial Therapeutic Product Introduction
11.5.4 Merck & Co. Inc. Revenue in Microbial Therapeutic Product Business (2020-2025)
11.5.5 Merck & Co. Inc. Recent Development
11.6 Biocon
11.6.1 Biocon Company Details
11.6.2 Biocon Business Overview
11.6.3 Biocon Microbial Therapeutic Product Introduction
11.6.4 Biocon Revenue in Microbial Therapeutic Product Business (2020-2025)
11.6.5 Biocon Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Microbial Therapeutic Product Introduction
11.7.4 Pfizer Revenue in Microbial Therapeutic Product Business (2020-2025)
11.7.5 Pfizer Recent Development
11.8 Dr. Reddy’s Laboratories Ltd.
11.8.1 Dr. Reddy’s Laboratories Ltd. Company Details
11.8.2 Dr. Reddy’s Laboratories Ltd. Business Overview
11.8.3 Dr. Reddy’s Laboratories Ltd. Microbial Therapeutic Product Introduction
11.8.4 Dr. Reddy’s Laboratories Ltd. Revenue in Microbial Therapeutic Product Business (2020-2025)
11.8.5 Dr. Reddy’s Laboratories Ltd. Recent Development
11.9 Intas Pharmaceuticals Ltd.
11.9.1 Intas Pharmaceuticals Ltd. Company Details
11.9.2 Intas Pharmaceuticals Ltd. Business Overview
11.9.3 Intas Pharmaceuticals Ltd. Microbial Therapeutic Product Introduction
11.9.4 Intas Pharmaceuticals Ltd. Revenue in Microbial Therapeutic Product Business (2020-2025)
11.9.5 Intas Pharmaceuticals Ltd. Recent Development
11.10 Novo Nordisk A/S
11.10.1 Novo Nordisk A/S Company Details
11.10.2 Novo Nordisk A/S Business Overview
11.10.3 Novo Nordisk A/S Microbial Therapeutic Product Introduction
11.10.4 Novo Nordisk A/S Revenue in Microbial Therapeutic Product Business (2020-2025)
11.10.5 Novo Nordisk A/S Recent Development
11.11 Eli Lilly and Company
11.11.1 Eli Lilly and Company Company Details
11.11.2 Eli Lilly and Company Business Overview
11.11.3 Eli Lilly and Company Microbial Therapeutic Product Introduction
11.11.4 Eli Lilly and Company Revenue in Microbial Therapeutic Product Business (2020-2025)
11.11.5 Eli Lilly and Company Recent Development
11.12 Sanofi S.A.
11.12.1 Sanofi S.A. Company Details
11.12.2 Sanofi S.A. Business Overview
11.12.3 Sanofi S.A. Microbial Therapeutic Product Introduction
11.12.4 Sanofi S.A. Revenue in Microbial Therapeutic Product Business (2020-2025)
11.12.5 Sanofi S.A. Recent Development
11.13 Boehringer Ingelheim
11.13.1 Boehringer Ingelheim Company Details
11.13.2 Boehringer Ingelheim Business Overview
11.13.3 Boehringer Ingelheim Microbial Therapeutic Product Introduction
11.13.4 Boehringer Ingelheim Revenue in Microbial Therapeutic Product Business (2020-2025)
11.13.5 Boehringer Ingelheim Recent Development
11.14 Bristol-Myers Squibb Company
11.14.1 Bristol-Myers Squibb Company Company Details
11.14.2 Bristol-Myers Squibb Company Business Overview
11.14.3 Bristol-Myers Squibb Company Microbial Therapeutic Product Introduction
11.14.4 Bristol-Myers Squibb Company Revenue in Microbial Therapeutic Product Business (2020-2025)
11.14.5 Bristol-Myers Squibb Company Recent Development
11.15 Abbot Laboratories
11.15.1 Abbot Laboratories Company Details
11.15.2 Abbot Laboratories Business Overview
11.15.3 Abbot Laboratories Microbial Therapeutic Product Introduction
11.15.4 Abbot Laboratories Revenue in Microbial Therapeutic Product Business (2020-2025)
11.15.5 Abbot Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Roche
Novartis
Amgen Inc
Merck& Co. Inc
Biocon Ltd.
Pfizer Inc
Dr. Reddy’s Laboratories Ltd.
Intas Pharmaceuticals Ltd
Novo Nordisk A S
Eli Lilly and Company
Sanofi
Boehringer Ingelheim
Bristol Myers Squibb Company
Abbot Laboratories
Viatris
List of Tables
 Table 1. Global Microbial Therapeutic Product Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Single Use Pre-Filled Injection/Injector Pen
 Table 3. Key Players of Multi-use Injectors
 Table 4. Key Players of Others
 Table 5. Global Microbial Therapeutic Product Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Microbial Therapeutic Product Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Microbial Therapeutic Product Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Microbial Therapeutic Product Market Share by Region (2020-2025)
 Table 9. Global Microbial Therapeutic Product Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Microbial Therapeutic Product Market Share by Region (2026-2031)
 Table 11. Microbial Therapeutic Product Market Trends
 Table 12. Microbial Therapeutic Product Market Drivers
 Table 13. Microbial Therapeutic Product Market Challenges
 Table 14. Microbial Therapeutic Product Market Restraints
 Table 15. Global Microbial Therapeutic Product Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Microbial Therapeutic Product Market Share by Players (2020-2025)
 Table 17. Global Top Microbial Therapeutic Product Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbial Therapeutic Product as of 2024)
 Table 18. Ranking of Global Top Microbial Therapeutic Product Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Microbial Therapeutic Product Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Microbial Therapeutic Product, Headquarters and Area Served
 Table 21. Global Key Players of Microbial Therapeutic Product, Product and Application
 Table 22. Global Key Players of Microbial Therapeutic Product, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Microbial Therapeutic Product Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Microbial Therapeutic Product Revenue Market Share by Type (2020-2025)
 Table 26. Global Microbial Therapeutic Product Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Microbial Therapeutic Product Revenue Market Share by Type (2026-2031)
 Table 28. Global Microbial Therapeutic Product Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Microbial Therapeutic Product Revenue Market Share by Application (2020-2025)
 Table 30. Global Microbial Therapeutic Product Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Microbial Therapeutic Product Revenue Market Share by Application (2026-2031)
 Table 32. North America Microbial Therapeutic Product Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Microbial Therapeutic Product Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Microbial Therapeutic Product Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Microbial Therapeutic Product Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Microbial Therapeutic Product Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Microbial Therapeutic Product Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Microbial Therapeutic Product Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Microbial Therapeutic Product Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Microbial Therapeutic Product Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Microbial Therapeutic Product Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Microbial Therapeutic Product Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Microbial Therapeutic Product Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Microbial Therapeutic Product Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Microbial Therapeutic Product Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Microbial Therapeutic Product Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Viatris Company Details
 Table 48. Viatris Business Overview
 Table 49. Viatris Microbial Therapeutic Product Product
 Table 50. Viatris Revenue in Microbial Therapeutic Product Business (2020-2025) & (US$ Million)
 Table 51. Viatris Recent Development
 Table 52. Roche Company Details
 Table 53. Roche Business Overview
 Table 54. Roche Microbial Therapeutic Product Product
 Table 55. Roche Revenue in Microbial Therapeutic Product Business (2020-2025) & (US$ Million)
 Table 56. Roche Recent Development
 Table 57. Novartis Company Details
 Table 58. Novartis Business Overview
 Table 59. Novartis Microbial Therapeutic Product Product
 Table 60. Novartis Revenue in Microbial Therapeutic Product Business (2020-2025) & (US$ Million)
 Table 61. Novartis Recent Development
 Table 62. Amgen Inc. Company Details
 Table 63. Amgen Inc. Business Overview
 Table 64. Amgen Inc. Microbial Therapeutic Product Product
 Table 65. Amgen Inc. Revenue in Microbial Therapeutic Product Business (2020-2025) & (US$ Million)
 Table 66. Amgen Inc. Recent Development
 Table 67. Merck & Co. Inc. Company Details
 Table 68. Merck & Co. Inc. Business Overview
 Table 69. Merck & Co. Inc. Microbial Therapeutic Product Product
 Table 70. Merck & Co. Inc. Revenue in Microbial Therapeutic Product Business (2020-2025) & (US$ Million)
 Table 71. Merck & Co. Inc. Recent Development
 Table 72. Biocon Company Details
 Table 73. Biocon Business Overview
 Table 74. Biocon Microbial Therapeutic Product Product
 Table 75. Biocon Revenue in Microbial Therapeutic Product Business (2020-2025) & (US$ Million)
 Table 76. Biocon Recent Development
 Table 77. Pfizer Company Details
 Table 78. Pfizer Business Overview
 Table 79. Pfizer Microbial Therapeutic Product Product
 Table 80. Pfizer Revenue in Microbial Therapeutic Product Business (2020-2025) & (US$ Million)
 Table 81. Pfizer Recent Development
 Table 82. Dr. Reddy’s Laboratories Ltd. Company Details
 Table 83. Dr. Reddy’s Laboratories Ltd. Business Overview
 Table 84. Dr. Reddy’s Laboratories Ltd. Microbial Therapeutic Product Product
 Table 85. Dr. Reddy’s Laboratories Ltd. Revenue in Microbial Therapeutic Product Business (2020-2025) & (US$ Million)
 Table 86. Dr. Reddy’s Laboratories Ltd. Recent Development
 Table 87. Intas Pharmaceuticals Ltd. Company Details
 Table 88. Intas Pharmaceuticals Ltd. Business Overview
 Table 89. Intas Pharmaceuticals Ltd. Microbial Therapeutic Product Product
 Table 90. Intas Pharmaceuticals Ltd. Revenue in Microbial Therapeutic Product Business (2020-2025) & (US$ Million)
 Table 91. Intas Pharmaceuticals Ltd. Recent Development
 Table 92. Novo Nordisk A/S Company Details
 Table 93. Novo Nordisk A/S Business Overview
 Table 94. Novo Nordisk A/S Microbial Therapeutic Product Product
 Table 95. Novo Nordisk A/S Revenue in Microbial Therapeutic Product Business (2020-2025) & (US$ Million)
 Table 96. Novo Nordisk A/S Recent Development
 Table 97. Eli Lilly and Company Company Details
 Table 98. Eli Lilly and Company Business Overview
 Table 99. Eli Lilly and Company Microbial Therapeutic Product Product
 Table 100. Eli Lilly and Company Revenue in Microbial Therapeutic Product Business (2020-2025) & (US$ Million)
 Table 101. Eli Lilly and Company Recent Development
 Table 102. Sanofi S.A. Company Details
 Table 103. Sanofi S.A. Business Overview
 Table 104. Sanofi S.A. Microbial Therapeutic Product Product
 Table 105. Sanofi S.A. Revenue in Microbial Therapeutic Product Business (2020-2025) & (US$ Million)
 Table 106. Sanofi S.A. Recent Development
 Table 107. Boehringer Ingelheim Company Details
 Table 108. Boehringer Ingelheim Business Overview
 Table 109. Boehringer Ingelheim Microbial Therapeutic Product Product
 Table 110. Boehringer Ingelheim Revenue in Microbial Therapeutic Product Business (2020-2025) & (US$ Million)
 Table 111. Boehringer Ingelheim Recent Development
 Table 112. Bristol-Myers Squibb Company Company Details
 Table 113. Bristol-Myers Squibb Company Business Overview
 Table 114. Bristol-Myers Squibb Company Microbial Therapeutic Product Product
 Table 115. Bristol-Myers Squibb Company Revenue in Microbial Therapeutic Product Business (2020-2025) & (US$ Million)
 Table 116. Bristol-Myers Squibb Company Recent Development
 Table 117. Abbot Laboratories Company Details
 Table 118. Abbot Laboratories Business Overview
 Table 119. Abbot Laboratories Microbial Therapeutic Product Product
 Table 120. Abbot Laboratories Revenue in Microbial Therapeutic Product Business (2020-2025) & (US$ Million)
 Table 121. Abbot Laboratories Recent Development
 Table 122. Research Programs/Design for This Report
 Table 123. Key Data Information from Secondary Sources
 Table 124. Key Data Information from Primary Sources
 Table 125. Authors List of This Report


List of Figures
 Figure 1. Microbial Therapeutic Product Picture
 Figure 2. Global Microbial Therapeutic Product Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Microbial Therapeutic Product Market Share by Type: 2024 VS 2031
 Figure 4. Single Use Pre-Filled Injection/Injector Pen Features
 Figure 5. Multi-use Injectors Features
 Figure 6. Others Features
 Figure 7. Global Microbial Therapeutic Product Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Microbial Therapeutic Product Market Share by Application: 2024 VS 2031
 Figure 9. Metabolic Disorders Case Studies
 Figure 10. Haematological Disorders Case Studies
 Figure 11. Oncology Case Studies
 Figure 12. Immunological Disorders Case Studies
 Figure 13. Infectious Diseases Case Studies
 Figure 14. Allergic Diseases Case Studies
 Figure 15. Others Case Studies
 Figure 16. Microbial Therapeutic Product Report Years Considered
 Figure 17. Global Microbial Therapeutic Product Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 18. Global Microbial Therapeutic Product Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global Microbial Therapeutic Product Market Share by Region: 2024 VS 2031
 Figure 20. Global Microbial Therapeutic Product Market Share by Players in 2024
 Figure 21. Global Top Microbial Therapeutic Product Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbial Therapeutic Product as of 2024)
 Figure 22. The Top 10 and 5 Players Market Share by Microbial Therapeutic Product Revenue in 2024
 Figure 23. North America Microbial Therapeutic Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. North America Microbial Therapeutic Product Market Share by Country (2020-2031)
 Figure 25. United States Microbial Therapeutic Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Canada Microbial Therapeutic Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Microbial Therapeutic Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Microbial Therapeutic Product Market Share by Country (2020-2031)
 Figure 29. Germany Microbial Therapeutic Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. France Microbial Therapeutic Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. U.K. Microbial Therapeutic Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Italy Microbial Therapeutic Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Russia Microbial Therapeutic Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Nordic Countries Microbial Therapeutic Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Microbial Therapeutic Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Microbial Therapeutic Product Market Share by Region (2020-2031)
 Figure 37. China Microbial Therapeutic Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Japan Microbial Therapeutic Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. South Korea Microbial Therapeutic Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Microbial Therapeutic Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. India Microbial Therapeutic Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Australia Microbial Therapeutic Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Microbial Therapeutic Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Microbial Therapeutic Product Market Share by Country (2020-2031)
 Figure 45. Mexico Microbial Therapeutic Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Brazil Microbial Therapeutic Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Microbial Therapeutic Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Microbial Therapeutic Product Market Share by Country (2020-2031)
 Figure 49. Turkey Microbial Therapeutic Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Microbial Therapeutic Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. UAE Microbial Therapeutic Product Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Viatris Revenue Growth Rate in Microbial Therapeutic Product Business (2020-2025)
 Figure 53. Roche Revenue Growth Rate in Microbial Therapeutic Product Business (2020-2025)
 Figure 54. Novartis Revenue Growth Rate in Microbial Therapeutic Product Business (2020-2025)
 Figure 55. Amgen Inc. Revenue Growth Rate in Microbial Therapeutic Product Business (2020-2025)
 Figure 56. Merck & Co. Inc. Revenue Growth Rate in Microbial Therapeutic Product Business (2020-2025)
 Figure 57. Biocon Revenue Growth Rate in Microbial Therapeutic Product Business (2020-2025)
 Figure 58. Pfizer Revenue Growth Rate in Microbial Therapeutic Product Business (2020-2025)
 Figure 59. Dr. Reddy’s Laboratories Ltd. Revenue Growth Rate in Microbial Therapeutic Product Business (2020-2025)
 Figure 60. Intas Pharmaceuticals Ltd. Revenue Growth Rate in Microbial Therapeutic Product Business (2020-2025)
 Figure 61. Novo Nordisk A/S Revenue Growth Rate in Microbial Therapeutic Product Business (2020-2025)
 Figure 62. Eli Lilly and Company Revenue Growth Rate in Microbial Therapeutic Product Business (2020-2025)
 Figure 63. Sanofi S.A. Revenue Growth Rate in Microbial Therapeutic Product Business (2020-2025)
 Figure 64. Boehringer Ingelheim Revenue Growth Rate in Microbial Therapeutic Product Business (2020-2025)
 Figure 65. Bristol-Myers Squibb Company Revenue Growth Rate in Microbial Therapeutic Product Business (2020-2025)
 Figure 66. Abbot Laboratories Revenue Growth Rate in Microbial Therapeutic Product Business (2020-2025)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Therapeutic Products from Microbe Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Microbial Therapeutic Products Market Research Report 2024
Microbial Fermenter Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Microbial Cell Fractionation Product Market Research Report 2025
Microbial Fermentation Service Market
Human Microbiome Therapeutic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Microbial Fermenters Market Research Report 2025
Composite Microbial Inoculant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Microbial Enzyme Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Microbial Algae Products Market Research Report 2024
Global Microbial Surfactant Market Research Report 2025
Microbial Septic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Microbial Antibacterial Drugs Market Research Report 2024
Microbial derived Fiber Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmaceutical Bioreactors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Medical Microbial Incubators Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Microbial Precision Fermentation Market Research Report 2025
Global Microbial Food Cultures Market Research Report 2025
Global Microbial Fermentation Technology for Food Market Research Report 2024
Global Microbiome Therapies Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions